Laura Marie Helleckes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laura Marie Helleckes has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Michael Osthege
Institute for Bio- and Geosciences (IBG-1), Forschungszentrum Jülich GmbH, Jülich, Germany
5 shared publications - Wolfgang Wiechert
Institute for Bio- and Geosciences (IBG-1), Forschungszentrum Jülich GmbH, Jülich, Germany
5 shared publications - Ehecatl Antonio del Rio Chanona
Imperial College London, Department of Chemical Engineering, London, United Kingdom
4 shared publications - Eric von Lieres
IBG‐1: Biotechnology Forschungszentrum Jülich Jülich Germany
4 shared publications - Marco Oldiges
Institute of Bio- and Geosciences IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany
4 shared publications Alessandro Butté
DataHow AG DataHow AG Switzerland
3 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Wiley in AIChE Journal
A human‐in‐the‐loop Bayesian optimization framework for constraint‐aware bioprocess development
We present Pareto Front Guided Sampling (PFGS), a human‐in‐the‐loop (HiL) Bayesian Optimization (BO) framework that reformulates surrogate‐model predictions as a multi‐objective optimization problem, allowing domain knowledge to be added intuitively to any BO problem. PFGS addresses constrained optimization by treating the posterior probability of constraint satisfaction as an explicit Pareto objective, and robust optimization via a Monte Carlo estimate of expected lower‐confidence performance under input perturbations, capturing likely degradation. The multi‐dimensional Pareto front makes trade‐offs between predicted performance, model uncertainty, constraint satisfaction, and robustness visible through pairwise two‐dimensional projections on an interactive dashboard, allowing selection criteria to be refined as the model and objectives evolve. The framework is showcased on a eight‐dimensional in‐silico fed‐batch Chinese Hamster Ovary cell culture case study. We showed improved performance over BO when the expert has perfect domain knowledge; however, PFGS is not designed to outperform BO, but rather to present a HiL acquisition function framework.
- 13 November 2026
- Published by Wiley in AIChE Journal
Open AccessA human‐in‐the‐loop Bayesian optimization framework for constraint‐aware bioprocess development
We present Pareto Front Guided Sampling (PFGS), a human‐in‐the‐loop (HiL) Bayesian Optimization (BO) framework that reformulates surrogate‐model predictions as a multi‐objective optimization problem, allowing domain knowledge to be added intuitively to any BO problem. PFGS addresses constrained optimization by treating the posterior probability of constraint satisfaction as an explicit Pareto objective, and robust optimization via a Monte Carlo estimate of expected lower‐confidence performance under input perturbations, capturing likely degradation. The multi‐dimensional Pareto front makes trade‐offs between predicted performance, model uncertainty, constraint satisfaction, and robustness visible through pairwise two‐dimensional projections on an interactive dashboard, allowing selection criteria to be refined as the model and objectives evolve. The framework is showcased on a eight‐dimensional in‐silico fed‐batch Chinese Hamster Ovary cell culture case study. We showed improved performance over BO when the expert has perfect domain knowledge; however, PFGS is not designed to outperform BO, but rather to present a HiL acquisition function framework.
- 20 March 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (4)
Front Cover Image, Volume 123, Number 4, April 2026
- 20 March 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (4)
Front Cover Image, Volume 123, Number 4, April 2026
- Open Access
- 6 February 2026
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 28 (8) , 3822-3836
CarAT: carbon atom tracing across industrial chemical value chains via chemistry language models
CarAT is a molecular-level framework for tracing carbon through industrial value chains, enabling biogenic carbon accounting to support crade-to-grave assessments, inform decarbon.
- 6 February 2026
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 28 (8) , 3822-3836
Open AccessCarAT: carbon atom tracing across industrial chemical value chains via chemistry language models
CarAT is a molecular-level framework for tracing carbon through industrial value chains, enabling biogenic carbon accounting to support crade-to-grave assessments, inform decarbon.
- Top Cited PapersOpen Access
- 8 January 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (4) , 805-830
A Guide to Bayesian Optimization in Bioprocess Engineering
Bayesian optimization has become widely popular across various experimental sciences due to its favorable attributes: it can handle noisy data, perform well with relatively small data sets, and provide adaptive suggestions for sequential experimentation. While still in its infancy, Bayesian optimization has recently gained traction in bioprocess engineering. However, experimentation with biological systems is highly complex and the resulting experimental uncertainty requires specific extensions to classical Bayesian optimization. Moreover, current literature often targets readers with a strong statistical background, limiting its accessibility for practitioners. In light of these developments, this review has two aims: first, to provide an intuitive and practical introduction to Bayesian optimization; and second, to outline promising application areas and open algorithmic challenges, thereby highlighting opportunities for future research in machine learning.
- 8 January 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (4) , 805-830
Top Cited PapersOpen AccessA Guide to Bayesian Optimization in Bioprocess Engineering
Bayesian optimization has become widely popular across various experimental sciences due to its favorable attributes: it can handle noisy data, perform well with relatively small data sets, and provide adaptive suggestions for sequential experimentation. While still in its infancy, Bayesian optimization has recently gained traction in bioprocess engineering. However, experimentation with biological systems is highly complex and the resulting experimental uncertainty requires specific extensions to classical Bayesian optimization. Moreover, current literature often targets readers with a strong statistical background, limiting its accessibility for practitioners. In light of these developments, this review has two aims: first, to provide an intuitive and practical introduction to Bayesian optimization; and second, to outline promising application areas and open algorithmic challenges, thereby highlighting opportunities for future research in machine learning.
- Open Access
- 28 November 2025
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 97, 103392
Perspectives for artificial intelligence in bioprocess automation
- 28 November 2025
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 97, 103392
Open AccessPerspectives for artificial intelligence in bioprocess automation
- Open Access
- 17 November 2025
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 96, 103382
Building trust in automated experimentation: uncertainty quantification in the era of high-throughput biolabs
- 17 November 2025
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 96, 103382
Open AccessBuilding trust in automated experimentation: uncertainty quantification in the era of high-throughput biolabs
- Open Access
Holistic Bioprocess Development Across Scales Using Multi-Fidelity Batch Bayesian Optimization
Bioprocesses are central to modern biotechnology, enabling sustainable production in pharmaceuticals, specialty chemicals, cosmetics, and food. However, developing high-performing processes is costly and complex, requiring iterative, multi-scale experimentation from microtiter plates to pilot reactors. Conventional Design of Experiments (DoE) approaches often struggle to address process scale-up and the joint optimization of reaction conditions and biocatalyst selection. We propose a multi-fidelity batch Bayesian optimization framework to accelerate bioprocess development and reduce experimental costs. The method integrates Gaussian Processes tailored for multi-fidelity modeling and mixed-variable optimization, guiding experiment selection across scales and biocatalysts. A custom simulation of a Chinese Hamster Ovary bioprocess, capturing non-linear and coupled scale-up dynamics, is used for benchmarking against multiple simulated industrial DoE baselines. Multiple case studies show how the proposed workflow can achieve a reduction in experimental costs and increased yield. This work provides a data-efficient strategy for bioprocess optimization and highlights future opportunities in transfer learning and uncertainty-aware design for sustainable biotechnology.
Open AccessHolistic Bioprocess Development Across Scales Using Multi-Fidelity Batch Bayesian Optimization
Bioprocesses are central to modern biotechnology, enabling sustainable production in pharmaceuticals, specialty chemicals, cosmetics, and food. However, developing high-performing processes is costly and complex, requiring iterative, multi-scale experimentation from microtiter plates to pilot reactors. Conventional Design of Experiments (DoE) approaches often struggle to address process scale-up and the joint optimization of reaction conditions and biocatalyst selection. We propose a multi-fidelity batch Bayesian optimization framework to accelerate bioprocess development and reduce experimental costs. The method integrates Gaussian Processes tailored for multi-fidelity modeling and mixed-variable optimization, guiding experiment selection across scales and biocatalysts. A custom simulation of a Chinese Hamster Ovary bioprocess, capturing non-linear and coupled scale-up dynamics, is used for benchmarking against multiple simulated industrial DoE baselines. Multiple case studies show how the proposed workflow can achieve a reduction in experimental costs and increased yield. This work provides a data-efficient strategy for bioprocess optimization and highlights future opportunities in transfer learning and uncertainty-aware design for sustainable biotechnology.
- Open Access
A Guide to Bayesian Optimization in Bioprocess Engineering
Bayesian optimization has become widely popular across various experimental sciences due to its favorable attributes: it can handle noisy data, perform well with relatively small datasets, and provide adaptive suggestions for sequential experimentation. While still in its infancy, Bayesian optimization has recently gained traction in bioprocess engineering. However, experimentation with biological systems is highly complex and the resulting experimental uncertainty requires specific extensions to classical Bayesian optimization. Moreover, current literature often targets readers with a strong statistical background, limiting its accessibility for practitioners. In light of these developments, this review has two aims: first, to provide an intuitive and practical introduction to Bayesian optimization; and second, to outline promising application areas and open algorithmic challenges, thereby highlighting opportunities for future research in machine learning.
Open AccessA Guide to Bayesian Optimization in Bioprocess Engineering
Bayesian optimization has become widely popular across various experimental sciences due to its favorable attributes: it can handle noisy data, perform well with relatively small datasets, and provide adaptive suggestions for sequential experimentation. While still in its infancy, Bayesian optimization has recently gained traction in bioprocess engineering. However, experimentation with biological systems is highly complex and the resulting experimental uncertainty requires specific extensions to classical Bayesian optimization. Moreover, current literature often targets readers with a strong statistical background, limiting its accessibility for practitioners. In light of these developments, this review has two aims: first, to provide an intuitive and practical introduction to Bayesian optimization; and second, to outline promising application areas and open algorithmic challenges, thereby highlighting opportunities for future research in machine learning.
- 12 July 2024
- Published by Wiley in Biotechnology Journal
- Vol. 19 (7) , e2400080
Novel calibration design improves knowledge transfer across products for the characterization of pharmaceutical bioprocesses
Modern machine learning has the potential to fundamentally change the way bioprocesses are developed. In particular, horizontal knowledge transfer methods, which seek to exploit data from historical processes to facilitate process development for a new product, provide an opportunity to rethink current workflows. In this work, we first assess the potential of two knowledge transfer approaches, meta learning and one‐hot encoding, in combination with Gaussian process (GP) models. We compare their performance with GPs trained only on data of the new process, that is, local models. Using simulated mammalian cell culture data, we observe that both knowledge transfer approaches exhibit test set errors that are approximately halved compared to those of the local models when two, four, or eight experiments of the new product are used for training. Subsequently, we address the question whether experiments for a new product could be designed more effectively by exploiting existing knowledge. In particular, we suggest to specifically design a few runs for the novel product to calibrate knowledge transfer models, a task that we coin calibration design. We propose a customized objective function to identify a set of calibration design runs, which exploits differences in the process evolution of historical products. In two simulated case studies, we observed that training with calibration designs yields similar test set errors compared to common design of experiments approaches. However, the former requires approximately four times fewer experiments. Overall, the results suggest that process development could be significantly streamlined when systematically carrying knowledge from one product to the next.
- 12 July 2024
- Published by Wiley in Biotechnology Journal
- Vol. 19 (7) , e2400080
Novel calibration design improves knowledge transfer across products for the characterization of pharmaceutical bioprocesses
Modern machine learning has the potential to fundamentally change the way bioprocesses are developed. In particular, horizontal knowledge transfer methods, which seek to exploit data from historical processes to facilitate process development for a new product, provide an opportunity to rethink current workflows. In this work, we first assess the potential of two knowledge transfer approaches, meta learning and one‐hot encoding, in combination with Gaussian process (GP) models. We compare their performance with GPs trained only on data of the new process, that is, local models. Using simulated mammalian cell culture data, we observe that both knowledge transfer approaches exhibit test set errors that are approximately halved compared to those of the local models when two, four, or eight experiments of the new product are used for training. Subsequently, we address the question whether experiments for a new product could be designed more effectively by exploiting existing knowledge. In particular, we suggest to specifically design a few runs for the novel product to calibrate knowledge transfer models, a task that we coin calibration design. We propose a customized objective function to identify a set of calibration design runs, which exploits differences in the process evolution of historical products. In two simulated case studies, we observed that training with calibration designs yields similar test set errors compared to common design of experiments approaches. However, the former requires approximately four times fewer experiments. Overall, the results suggest that process development could be significantly streamlined when systematically carrying knowledge from one product to the next.
- Open Access
- 29 March 2024
- Published by Wiley
Calibration design for pharmaceutical bioprocesses: A novel approach for knowledge transfer in Design of Experiments
Modern machine learning methods, and their use alongside established paradigms such as Quality by Design, have the potential to fundamentally change the way bioprocesses are developed. In particular, horizontal knowledge transfer methods, which seek to exploit data from historical processes to facilitate process development for a new product, provide an opportunity to rethink process development workflows. In this work, we firstly assess the potential of two knowledge transfer approaches, meta learning and one-hot encoding, in combination with Gaussian process (GP) models. We compare their performance to GPs developed only on data of the new process. Using simulated mammalian cell cultivation data, we observe that both knowledge transfer approaches outperform the individual-product approach. In the second part, we address the question whether experiments for a new product could be designed more effectively by exploiting existing knowledge. In particular, we suggest to specifically design few runs for the novel product to calibrate knowledge transfer models, a task that we coin calibration design. We propose a novel, customised metric to identify a set of calibration design runs, which exploits differences in process evolutions of historical products. In two simulated case studies, we observed that training with calibration designs yields similar test set errors compared to common approaches of Design of Experiments. However, much fewer experiments are needed for the former, suggesting an interesting alternative for future bioprocess development. Overall, the results suggest that process development could be significantly streamlined when systematically carrying knowledge from one product to the next.
- 29 March 2024
- Published by Wiley
Open AccessCalibration design for pharmaceutical bioprocesses: A novel approach for knowledge transfer in Design of Experiments
Modern machine learning methods, and their use alongside established paradigms such as Quality by Design, have the potential to fundamentally change the way bioprocesses are developed. In particular, horizontal knowledge transfer methods, which seek to exploit data from historical processes to facilitate process development for a new product, provide an opportunity to rethink process development workflows. In this work, we firstly assess the potential of two knowledge transfer approaches, meta learning and one-hot encoding, in combination with Gaussian process (GP) models. We compare their performance to GPs developed only on data of the new process. Using simulated mammalian cell cultivation data, we observe that both knowledge transfer approaches outperform the individual-product approach. In the second part, we address the question whether experiments for a new product could be designed more effectively by exploiting existing knowledge. In particular, we suggest to specifically design few runs for the novel product to calibrate knowledge transfer models, a task that we coin calibration design. We propose a novel, customised metric to identify a set of calibration design runs, which exploits differences in process evolutions of historical products. In two simulated case studies, we observed that training with calibration designs yields similar test set errors compared to common approaches of Design of Experiments. However, much fewer experiments are needed for the former, suggesting an interesting alternative for future bioprocess development. Overall, the results suggest that process development could be significantly streamlined when systematically carrying knowledge from one product to the next.